Simple 1-hour trading strategy revealed

A note from our friends at Base Camp Trading(ad)

Dear Income Seeker,

If you’re struggling to find high-probability income trades…

Or think you’ve found them…

Only to be frustrated – and disappointed – with the money you’re bringing in…

You owe it to yourself to check out this website.

Because it will give you the opportunity to get your hands on a little-known 1-hour trading secret… 100% free of charge.

Do your future self a big favor and claim a copy now.

Because at some point soon, it won’t be free.

Details here.

To better trading,

– Drew Day
Partner
Base Camp Trading

 
 
 
Bonus Article

Nike Yields More Than Any Dow Stock. The Math Is the Problem.

Hey there, bargain hunter. Nike is sitting at $35.51, a 12-year low, and it now pays the fattest dividend yield of any stock in the Dow Jones Industrial Average. That combination sounds like a screaming value. Before you load up, you need to understand exactly what is holding that payout up, and what could knock it over.

Scoreboard

NKE closed Friday at $35.51, down 2.34% on the session. That puts it about 78% below its 2021 closing high (around $161.56). The 52-week range runs from $35.50 to $76.97. On September 15, shares broke below the prior 52-week floor of $37.95. Volume on Friday ran to 52 million shares against a roughly 52 million daily average. Nike also exits the S&P 100 index on September 21, after an 18-year tenure.

Why It Keeps Falling

The business itself tells the story. Full-year fiscal 2026 revenue was $46.4 billion, flat on a reported basis and down 2% in currency-neutral terms. Net income came in at $3.1 billion, down 3%. Nike Direct revenues fell to $17.7 billion from $18.8 billion the prior year, with NIKE Brand Digital down 12% as traffic dried up. China has now posted eight consecutive quarters of declines.

Wall Street has stopped giving the benefit of the doubt. Morgan Stanley reinstated with an Underweight rating and a $31 target. BMO Capital initiated with an Underperform and a $30 target, citing slowing lifestyle demand and structurally lower margins. BMO sees a full EPS recovery to $3 not arriving until fiscal 2031. JPMorgan figures fiscal 2027 EPS could land 10% below consensus, and fiscal 2028 EPS 20% below. Baird downgraded to Neutral. UBS cut its target on September 18 and flagged that Q1 fiscal 2027 EPS is likely to miss consensus by $0.05.

The Dividend: Coverage Is the Question

Nike pays $0.41 per quarter, or $1.64 annually. The yield at Friday’s close is roughly 4.6%, well above the 1.89% consumer discretionary sector average. The next $0.41 payment lands October 1, the same day as the earnings report. That coincidence is not trivia: it means you are collecting yield from a company reporting results that Wall Street expects to disappoint, on the same day.

The payout ratio sits at roughly 78%, based on fiscal 2026 diluted EPS of $2.10. Free cash flow for the year was about $2.18 billion against $2.41 billion paid as common dividends. That is not a tight margin. That is a coverage gap. Operating cash flow for the first nine months of fiscal 2026 was $1.23 billion, a sharp drop from $3.24 billion in the same period the prior year. Cash and short-term investments still total about $9.0 billion, so the balance sheet is not in distress. But the trend in cash generation is the wrong direction.

Nike has raised its dividend for 24 consecutive years. A 25th straight increase in November 2026 would put it into Dividend Aristocrat territory, assuming it remains in the S&P 500. That streak creates institutional pressure to keep raising, even when the business is shrinking. Streaks end eventually.

Bull / Base / Bear

  • Bull: Earnings on October 1 surprise to the upside. Comparable numbers from a year ago are soft, so the hurdle is low. Consensus EPS sits around $0.45. A beat plus encouraging Q2 guidance could trigger a sharp short-covering rally from depressed levels. Needham’s $75 target implies the stock roughly doubles.
  • Base: Results are in line but Q2 guidance disappoints, as UBS expects. Stock grinds sideways to slightly lower. The dividend holds. Turnaround under CEO Elliott Hill continues, but the timeline stays measured in years, not quarters.
  • Bear: China deteriorates further, margins compress without tariff tailwinds, and the dividend payout ratio approaches levels that make the next raise questionable. BMO’s $30 target represents another 15% downside from here.

Action Plan

Do not buy size into a report on October 1 when multiple brokers have Sell ratings and the options market is pricing a 6-7% move on a stock that has historically moved more. If you want exposure, a half-position now captures the yield, then size up only after you see Q1 results and, critically, Q2 guidance. The roughly $9 billion cash pile and 24-year dividend streak give Nike the resources to protect the payout even through a rough patch. That is not the same as saying the stock is cheap.

Cheap Investor Checklist

  • Dividend yield vs. payout ratio: 4.6% yield but 78% payout on shrinking EPS is not a free lunch
  • Free cash flow coverage: about $2.18 billion FCF vs. $2.41 billion of dividends paid, not covered
  • Cash buffer: about $9.0 billion in cash and short-term investments provides near-term protection
  • China trajectory: eight straight quarterly declines; Q1 2027 commentary is the key variable
  • Direct channel: NIKE Direct down 6% for the full year; NIKE Brand Digital down 12%
  • Gross margin watch: Q4 diluted EPS included a large benefit tied to the expected recovery of IEEPA tariffs; underlying Q1 margin is the real read
  • Analyst skew: 23 of 36 analysts rate NKE hold or worse
  • Index pressure: S&P 100 removal on September 21 adds passive selling overhang
  • Q2 guidance: any revenue decline forecast will matter more than the Q1 number itself
  • Aristocrat clock: a 25th consecutive dividend raise in November is the income investor’s anchor

Bottom Line

If Q1 results on October 1 show China stabilizing and Q2 guidance comes in above consensus, NKE at $35 with a $1.64 dividend is a legitimate deep-value entry for patient income investors. If guidance disappoints, the yield is not high enough to compensate for the earnings risk ahead. Wait for the report. The dividend lands the same day anyway.